Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1440]

New strategy for ecancermedicalscience: supporting publications in under...

Prof Richard Sullivan (Chair of Trustees, ecancer Global Foundation) and Dr...

New strategy for ecancermedicalscience: supporting publications in under-resourced settings ( Prof Richard Sullivan (Chair of Trustees, ecancer Global Foundation) and Dr Eduardo Cazap (Editor in chief, ecancer, President, SLACOM) )

Oncology pharmacist perspective on PARP inhibitors for castration-resistant...

Dr Grace Martin - The University of Kansas Cancer Center, Kansas City, USA

Oncology pharmacist perspective on PARP inhibitors for castration-resistant prostate cancer ( Dr Grace Martin - The University of Kansas Cancer Center, Kansas City, USA )

Laboratory analysis of CDH1 missense mutation

Prof. Raquel Seruca - IPATIMUP-I3S, Porto, Portugal

Laboratory analysis of CDH1 missense mutation ( Prof. Raquel Seruca - IPATIMUP-I3S, Porto, Portugal )

The European Cancer Prevention Organization

Prof. Jaak Janssens - Hasselt, Belgium

The European Cancer Prevention Organization ( Prof. Jaak Janssens - Hasselt, Belgium )

Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )

Meet the Expert: Daniel Seymour

Daniel Seymour - BIO Ventures for Global Health, Seattle, USA

Meet the Expert: Daniel Seymour ( Daniel Seymour - BIO Ventures for Global Health, Seattle, USA )

COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected...

Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany

COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected stage III BRAF V600–mutant melanoma ( Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )

Medical oncology care amidst the COVID-19 pandemic at the National University...

Dr Marvin Mendoza - University of the Philippines - Philippine General Hospital...

Medical oncology care amidst the COVID-19 pandemic at the National University Hospital in the Philippines ( Dr Marvin Mendoza - University of the Philippines - Philippine General Hospital, Manila, Philippines )

Preclinical models for small-cell lung cancer

Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands

Preclinical models for small-cell lung cancer ( Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )

Conducting Oncology Clinical Trials in Africa II: Regulatory Process for...

Mr Dennis Ake, MSc.

Conducting Oncology Clinical Trials in Africa II: Regulatory Process for Clinical Trials in Africa ( Mr Dennis Ake, MSc. )

Pembrolizumab vs brentuximab vedotin in relapsed or refractory classic Hodgkin...

Dr John Kuruvilla - Princess Margaret Cancer Centre, Toronto, Canada

$Pembrolizumab vs brentuximab vedotin in relapsed or refractory classic Hodgkin lymphoma ( Dr John Kuruvilla - Princess Margaret Cancer Centre, Toronto, Canada )$

Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for...

Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA

Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for resectable pancreatic ductal adenocarcinoma ( Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA )

More from ecancer